Last reviewed · How we verify

NCT04845854

Prevalence of Oral Side Effects Associated With Chemo and Radiotherapy for Treating Head and Neck Cancer

Completed Last updated 14 February 2023
What this trial tests

trial in Oral Complications of Chemotherapy and Head and Neck Radiation in 294 participants. Completed in 3 September 2022.

Timeline
2 October 2020
Primary endpoint
20 February 2022
3 September 2022

Quick facts

Lead sponsorCairo University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment294
Start date2 October 2020
Primary completion20 February 2022
Estimated completion3 September 2022
Sites1 location across Egypt

Conditions studied

Sponsor

Cairo University

Who can join

Adults 20 to 70, any sex, with Oral Complications of Chemotherapy and Head and Neck Radiation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A cross-sectional study will be conducted to report oral complications during chemo and radiotherapy treatment in case of patients diagnosed with head and neck cancer and the effect of theses oral side effects on patients' quality of life which will in turn allow the implication of preventive measures

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04845854.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing